Flunoxaprofen

Flunoxaprofen
Clinical data
ATC code	G02CC04 (WHO) M01AE15 (WHO);
Identifiers
	IUPAC name (2S)-2-[2-(4-fluorophenyl)-1,3-benzoxazol-5-yl]propanoic acid;
CAS Number	66934-18-7 ;
PubChem CID	68869;
ChemSpider	62101 ;
UNII	UKU5U19W9M;
KEGG	D07219 ;
ChEBI	CHEBI:76154 ;
ChEMBL	ChEMBL1614641 ;
CompTox Dashboard (EPA)	DTXSID00912311 ;
Chemical and physical data
Formula	C16H12FNO3
Molar mass	285.274 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C[C@@H](c1ccc2c(c1)nc(o2)c3ccc(cc3)F)C(=O)O;
	InChI InChI=1S/C16H12FNO3/c1-9(16(19)20)11-4-7-14-13(8-11)18-15(21-14)10-2-5-12(17)6-3-10/h2-9H,1H3,(H,19,20)/t9-/m0/s1 ; Key:ARPYQKTVRGFPIS-VIFPVBQESA-N ;
	(what is this?) (verify)

Flunoxaprofen, also known as Priaxim, is a chiral nonsteroidal anti-inflammatory drug (NSAID). It is closely related to naproxen, which is also an NSAID. Flunoxaprofen has been shown to significantly improve the symptoms of osteoarthritis and rheumatoid arthritis. The clinical use of flunoxaprofen has ceased due to concerns of potential hepatotoxicity.

Clinical data


ATC code	G02CC04 (WHO) M01AE15 (WHO)
Identifiers
IUPAC name (2S)-2-[2-(4-fluorophenyl)-1,3-benzoxazol-5-yl]propanoic acid
CAS Number	66934-18-7^Y
PubChem CID	68869
ChemSpider	62101^N
UNII	UKU5U19W9M
KEGG	D07219^Y
ChEBI	CHEBI:76154^N
ChEMBL	ChEMBL1614641^N
CompTox Dashboard (EPA)	DTXSID00912311
Chemical and physical data
Formula	C₁₆H₁₂FNO₃
Molar mass	285.274 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES C[C@@H](c1ccc2c(c1)nc(o2)c3ccc(cc3)F)C(=O)O
InChI InChI=1S/C16H12FNO3/c1-9(16(19)20)11-4-7-14-13(8-11)18-15(21-14)10-2-5-12(17)6-3-10/h2-9H,1H3,(H,19,20)/t9-/m0/s1^N Key:ARPYQKTVRGFPIS-VIFPVBQESA-N^N
^NY (what is this?) (verify)